32 reports

Global DNA and RNA Isolation Kits Figure ##.

  • DNA
  • Genomics
  • RNA
  • APAC
  • World

Targeted DNA/ RNA Sequencing Market Analysis By Technology, By Workflow, By Application, By Type, By End-use And Segment Forecasts, 2014 - 2025 Chapter ## Research Methodology ##. ## Information Procurement ##. ##. ## Purchased Database ##. ##. ## GVR’s Internal Database ##. ## Data Analysis ##.

  • Genomics
  • RNA
  • United States
  • Demand
  • Forecast
  • NORTH AMERICA: RNA-FISH MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • GLOBAL RNA-FISH MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)

The in situ hybridization market is projected to reach USD 739.9 million by 2021 from USD 557.1 million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are some...

  • RNA
  • United States
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Other prominent vendors
  • Global nucleic acid isolation and purification market 2016-2021 ($ mn)

It offers product such as bioZOLTM-G RNA Isolation Reagent and All-in-One (RNA/ DNA/ Protein) Purification Kit.

  • RNA
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Limited
  • Thermo Fisher Scientific, Inc.
  • RNA Aptamer
  • 6.3 RNA-BASED APTAMERS

The global aptamers market is expected to reach $244.93 million by 2020 from $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 and 2020. The aptamer type segments included in this report are DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. Based on applications, the report is segmented into diagnostics, therapeutics...

  • RNA
  • United States
  • Base Pair Biotechnologies, Inc.
  • SomaLogic, Inc.
  • Vivonics, Inc.

Indicated by CTC cfDNA-RNA 2015 participants (Study ##) Table ##. ##.

  • Genomics
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • RNA
  • LOW REPRESENTATION OF MIRNA AMONG RNA SPECIES
  • THREE: MIRNA PROFILING AND FUNCTIONAL ANALYSIS TECHNOLOGIES 73

MicroRNA Tools and Services Market examines the overall market for miRNA analysis tools and services. The miRNA marketplace is dynamic, driven by constant innovation and translation of scientific knowledge to clinical applications. The report includes the following market information: Estimated Market Breakdown by Tools...

  • RNA
  • Illumina, Inc.
  • Mirna Therapeutics, Inc.
  • QIAGEN N.V.
  • Sigma-Aldrich
  • RNA Disruption Assay - Breast Cancer - Product Description
  • RNA Disruption Assay - Breast Cancer - Product Status

Summary Rna Diagnostics Inc (Rna Diagnostics) is a medical device company that develops medical diagnostics molecular diagnostic technologies. The company provides solutions to manage cancer and other disease states. It offers diagnostic tools used in treatment of women undergoing chemotherapy for breast cancer. Rna Diagnostics’...

  • RNA
  • Canada
  • Company
  • Product Initiative
  • GlobalData's company
  • R&D Progress Research and Development Brief
  • R&D Progress Research and Development Brief

Probable ATP Dependent RNA Helicase DDX## (DEAD Box Protein ## or RIG I Like Receptor ## or Retinoic Acid Inducible Gene ## Protein or DDX## or EC ##. ##. ##. ##) - Pipeline Review, H## 2017 Reference Code: GMDHC##TDB Publication Date: November 2017 Introduction GLOBAL MARKETS DI

  • DNA
  • RNA
  • World
  • Product Initiative
  • Rigontec GmbH
  • PIPELINE BY RIGONTEC GMBH, H1 2017
  • (SB-9200 + HBV NUCLEOSIDE/TIDES) - DRUG PROFILE

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H1 2017 Summary Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein...

  • RNA
  • Turkey
  • World
  • Product Initiative
  • Rigontec GmbH
  • 2.2.3 RNA
  • 2.3.4 CIRCULATING RNA IN PREGNANCY

ES.1 Introduction to the Non-invasive Prenatal Diagnostics Market The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used as a non-invasive method for prenatal diagnostics. The report will also provide a market analysis of the market value,...

  • RNA
  • Ariosa Diagnostics, Inc.
  • Illumina, Inc.
  • Natera, Inc.
  • Sequenom, Inc.
  • 2.2.3 RNA
  • 2.2.2 CIRCULATING EXTRACELLULAR DNA

ES.1 Introduction to the Circulating Nucleic Acid Market Report The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact on making the ongoing research closer to clinical application. The...

  • RNA
  • World
  • Affymetrix, Inc.
  • QIAGEN N.V.
  • Roche Group
  • EOSCAPE-HCV RNA - PRODUCT STATUS
  • FTD HEPATITIS C RNA ASSAY - PRODUCT DESCRIPTION

Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017" provides an overview of Hepatitis Viruses Rapid Tests & POC (Point Of Care)...

  • Hepatitis
  • RNA
  • United States
  • Demand
  • GlobalData's company
  • ESYSTEM - QUALITATIVE HCV RNA ASSAY - PRODUCT DESCRIPTION
  • ESYSTEM - QUALITATIVE HCV RNA ASSAY - PRODUCT STATUS

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Hepatitis Viruses Diagnostic Tests currently in pipeline stage. The report...

  • Clinical Trial
  • Hepatitis
  • Molecular Diagnostic
  • RNA
  • GlobalData's company
  • NOV 08, 2017: SERACARE ANNOUNCES INDUSTRY'S FIRST COMPREHENSIVE NGS REFERENCE MATERIAL FOR HEMATOLOGIC MALIGNANCIES

This fully packaged RNA virus closely resembles natural Zika virus genetically, containing the entire RNA genome of the ZIKV 2007 strain.

  • Medical Device
  • RNA
  • United States
  • Supply
  • SeraCare Life Sciences, Inc.
  • VENTURE FINANCING
  • SYNTHETIC GENOMICS ENTERS INTO LICENSING AGREEMENT WITH ARCTURUS THERAPEUTICS

Summary Arcturus Therapeutics Inc (Arcturus) is a research and development company that develops RNA medicines for the treatment of rare diseases. The company’s pipeline products include RNA medicines, being developed for indications such as cystic fibrosis, OTC deficiency, TTR amyloidosis, hepatitis B and alpha-1-antitrypsin...

  • Pharmaceutical
  • RNA
  • Therapy
  • United States
  • Arcturus Therapeutics, Inc.
  • FEB 11, 2016: QIAGEN LAUNCHES TARGETED RNA PANELS FOR NEXT-GENERATION SEQUENCING
  • APR 14, 2016: QIAGEN LAUNCHES STREAMLINED BIOINFORMATICS FOR RNA SEQUENCING OF LIQUID BIOPSIES

Summary Qiagen NV (Qiagen) is a provider of molecular testing solutions. Its solutions include sample and assay technologies, bioinformatics and automation systems. Qiagen’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue. The company’s product portfolio...

  • Diagnostics
  • Medical Device
  • Molecular Diagnostic
  • RNA
  • QIAGEN N.V.
  • SMALL MOLECULE TO TARGET RNA FOR MYOTONIC DYSTROPHY - DRUG PROFILE
  • SMALL MOLECULES TO TARGET RNA FOR MYOTONIC DYSTROPHY - DRUG PROFILE

Myotonic Dystrophy - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myotonic Dystrophy - Pipeline Review, H2 2016’, provides an overview of the Myotonic Dystrophy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myotonic Dystrophy, complete...

  • RNA
  • United States
  • World
  • Company Operations
  • Product Initiative
  • MAR 23, 2017: NANOSTRING LAUNCHES NEW PLEXSET TECHNOLOGY AS AN ALTERNATIVE TO QPCR FOR MULTIPLEXED HIGH-THROUGHPUT GENE EXPRESSION STUDIES
  • Deal Type

The nCounter Low RNA Input Kit enables nCounter Gene Expression analysis to be performed with sample inputs ranging from ##-## ng, depending on sample quality.

  • Medical Device
  • RNA
  • United States
  • Company
  • NanoString Technologies, Inc.
  • BIOSEARCH TECHNOLOGIES ENTERS INTO LICENSING AGREEMENT WITH RUTGERS UNIVERSITY FOR TURBOFISH TECHNOLOGY

Being able to perform a protocol in ## minutes (or sometimes as little as ## seconds) with virtually no loss in signal integrity marks a huge shift in our conception of what one can do with RNA FISH. "

  • Genomics
  • RNA
  • United States
  • M&A
  • GlobalData's company
  • BIOSEARCH TECHNOLOGIES ENTERS INTO LICENSING AGREEMENT WITH RUTGERS UNIVERSITY FOR TURBOFISH TECHNOLOGY

Being able to perform a protocol in ## minutes (or sometimes as little as ## seconds) with virtually no loss in signal integrity marks a huge shift in our conception of what one can do with RNA FISH. "

  • Genomics
  • Pharmaceutical
  • RNA
  • United States
  • M&A

The series ## convertible preferred stock does not have voting rights.

  • Pharmaceutical
  • RNA
  • United States
  • Company
  • Takara Bio Inc.
  • GLOBAL ELECTROPHORESIS REAGENTS MARKET SIZE FOR DNA & RNA ANALYSIS, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • REST OF EUROPE: ELECTROPHORESIS REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)

The global electrophoresis reagents market is expected to grow at a CAGR of 5.4% during the forecast period of 2015-2020 and is estimated to be worth 1.05 billion by 2020. The market is mainly driven by the increasing research activities in the life sciences, pharmaceutical, and biotechnology industries; technological advancements; rapidly...

  • RNA
  • North America
  • United States
  • World
  • Market Size

We' ve even pushed the input as low as ## ng for very high quality total RNA.

  • Genomics
  • RNA
  • United States
  • Deals & Alliance
  • New England Biolabs, Inc.
  • JUN 15, 2017: PROQR R&D DAY HIGHLIGHTS PROGRESS ON PIPELINE AND INTRODUCES AXIOMER, A NOVEL PROPRIETARY RNA TECHNOLOGY
  • JUN 15, 2017: PROQR R&D DAY HIGHLIGHTS PROGRESS ON PIPELINE AND INTRODUCES AXIOMER, A NOVEL PROPRIETARY RNA TECHNOLOGY

Summary ProQR Therapeutics NV (ProQR) is a biotech company that discovers and develops drugs for the treatment of genetic disorders.The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide that is designed to treat Leber’s congenital...

  • Pharmaceutical
  • RNA
  • Therapy
  • United States
  • ProQR Therapeutics N.V.
  • FTD HEPATITIS E RNA ASSAY - PRODUCT STATUS
  • FTD HDV RNA ASSAY - PRODUCT DESCRIPTION

Hepatitis Viruses - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Hepatitis Viruses - Pipeline Review, 2015" provides an overview of Hepatitis Viruses diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative...

  • Clinical Trial
  • Hepatitis
  • Molecular Diagnostic
  • RNA
  • GlobalData's company
  • Small Molecules to Inhibit RNA Dependent RNA Polymerase for Common Cold
  • Small Molecules to Inhibit RNA Dependent RNA Polymerase for Dengue Virus Infections

Cocrystal Pharma, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Cocrystal Pharma, Inc. - Product Pipeline Review - 2016’, provides an overview of the Cocrystal Pharma, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics...

  • Pharmaceutical
  • RNA
  • United States
  • Company Operations
  • Cocrystal Pharma, Inc.

RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.

  • In Vitro Diagnostics
  • Molecular Diagnostic
  • RNA
  • World
  • Demand
  • Indication
  • Application

Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. It offers liquid biopsy tests kits, EXO50 kits, EXO60 kits and EXO70 kits. Exosome Diagnostics’...

  • Diagnostics
  • Prostate Cancer
  • RNA
  • United States
  • Exosome Diagnostics, Inc.
  • Myotonic Dystrophy - Product Development Milestones
  • Drug Profiles

Myotonic Dystrophy - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Myotonic Dystrophy - Pipeline Review, H1 2016’, provides an overview of the Myotonic Dystrophy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myotonic Dystrophy, complete...

  • Pharmaceutical
  • RNA
  • Therapy
  • United States